Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
FOSMANOGEPIX
(2)
Small molecule
GPI-anchored wall transfer protein 1 inhibitor
Unknown
Investigational
Unknown
FOSMANOGEPIX
×
Maximum Phase:
2
First Approval:
None
UNII:
1XQ871489P
Molecule Type:
Small molecule
Molecular Formula:
C22H21N4O6P
Molecular Weight:
468.41
AlogP:
2.21
PSA:
147.64
HBD:
2.0
HBA:
#RotB:
9.0
Source:
LY-2606368
(2)
Small molecule
Serine/threonine-protein kinase Chk1 inhibitor
Unknown
Investigational
Unknown
LY-2606368
×
Maximum Phase:
2
First Approval:
None
UNII:
820NH671E6
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FALLYPRIDE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
FALLYPRIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
G9FWZ369GX
Molecule Type:
Small molecule
Molecular Formula:
C20H29FN2O3
Molecular Weight:
364.46
AlogP:
2.99
PSA:
50.8
HBD:
1.0
HBA:
#RotB:
10.0
Source:
ICENTICAFTOR
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
ICENTICAFTOR
×
Maximum Phase:
2
First Approval:
None
UNII:
AMB0BO0WFH
Molecule Type:
Small molecule
Molecular Formula:
C12H13F6N3O3
Molecular Weight:
361.24
AlogP:
1.73
PSA:
97.47
HBD:
3.0
HBA:
#RotB:
4.0
Source:
E-7016
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
E-7016
×
Maximum Phase:
2
First Approval:
None
UNII:
M8926C7ILX
Molecule Type:
Small molecule
Molecular Formula:
C20H19N3O3
Molecular Weight:
349.39
AlogP:
2.65
PSA:
78.45
HBD:
2.0
HBA:
#RotB:
2.0
Source:
ATOPAXAR
(2)
Small molecule
Proteinase-activated receptor 1 antagonist
Unknown
Investigational
Unknown
ATOPAXAR
×
Maximum Phase:
2
First Approval:
None
UNII:
HTI275SD2D
Molecule Type:
Small molecule
Molecular Formula:
C29H38FN3O5
Molecular Weight:
527.64
AlogP:
4.79
PSA:
84.32
HBD:
1.0
HBA:
#RotB:
9.0
Source:
PERPHENAZINE 4-AMINOBUTYRATE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
PERPHENAZINE 4-AMINOBUTYRATE
×
Maximum Phase:
2
First Approval:
None
UNII:
K1WO7H97QZ
Molecule Type:
Small molecule
Molecular Formula:
C25H33ClN4O2S
Molecular Weight:
489.09
AlogP:
4.23
PSA:
62.04
HBD:
1.0
HBA:
#RotB:
10.0
Source:
ABT-072
(2)
Small molecule
Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor
Unknown
Investigational
Unknown
ABT-072
×
Maximum Phase:
2
First Approval:
None
UNII:
PSQ4R5K1QI
Molecule Type:
Small molecule
Molecular Formula:
C24H27N3O5S
Molecular Weight:
469.56
AlogP:
3.37
PSA:
110.26
HBD:
2.0
HBA:
#RotB:
6.0
Source:
RAF-265
(2)
Small molecule
Serine/threonine-protein kinase B-raf inhibitor
Unknown
Investigational
Unknown
RAF-265
×
Maximum Phase:
2
First Approval:
None
UNII:
8O434L3768
Molecule Type:
Small molecule
Molecular Formula:
C24H16F6N6O
Molecular Weight:
518.42
AlogP:
6.93
PSA:
80.65
HBD:
2.0
HBA:
#RotB:
5.0
Source:
PF-06459988
(2)
Small molecule
Epidermal growth factor receptor erbB1 inhibitor
Unknown
Investigational
Unknown
PF-06459988
×
Maximum Phase:
2
First Approval:
None
UNII:
5IE92SK9EB
Molecule Type:
Small molecule
Molecular Formula:
C19H22ClN7O3
Molecular Weight:
431.88
AlogP:
2.13
PSA:
110.19
HBD:
2.0
HBA:
#RotB:
7.0
Source:
CUDETAXESTAT
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
CUDETAXESTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GTS-21
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
GTS-21
×
Maximum Phase:
2
First Approval:
None
UNII:
8S399XDN2K
Molecule Type:
Small molecule
Molecular Formula:
C19H20N2O2
Molecular Weight:
308.38
AlogP:
3.77
PSA:
43.71
HBD:
0.0
HBA:
#RotB:
4.0
Source:
RISLENEMDAZ
(2)
Small molecule
Glutamate NMDA receptor; GRIN1/GRIN2B antagonist
Unknown
Investigational
Unknown
RISLENEMDAZ
×
Maximum Phase:
2
First Approval:
None
UNII:
5HAM167S5T
Molecule Type:
Small molecule
Molecular Formula:
C19H23FN4O2
Molecular Weight:
358.42
AlogP:
3.19
PSA:
67.35
HBD:
1.0
HBA:
#RotB:
5.0
Source:
TEZAMPANEL
(2)
Small molecule
Glutamate receptor ionotropic AMPA antagonist
Unknown
Investigational
Unknown
TEZAMPANEL
×
Maximum Phase:
2
First Approval:
None
UNII:
6XN50U405Y
Molecule Type:
Small molecule
Molecular Formula:
C13H21N5O2
Molecular Weight:
279.34
AlogP:
0.61
PSA:
103.79
HBD:
3.0
HBA:
#RotB:
4.0
Source:
CGC-11047
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
CGC-11047
×
Maximum Phase:
2
First Approval:
None
UNII:
HU43305R7O
Molecule Type:
Small molecule
Molecular Formula:
C14H32N4
Molecular Weight:
256.44
AlogP:
0.72
PSA:
48.12
HBD:
4.0
HBA:
#RotB:
14.0
Source:
VOROLANIB
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
VOROLANIB
×
Maximum Phase:
2
First Approval:
None
UNII:
YP8G3I74EL
Molecule Type:
Small molecule
Molecular Formula:
C23H26FN5O3
Molecular Weight:
439.49
AlogP:
2.75
PSA:
97.54
HBD:
3.0
HBA:
#RotB:
3.0
Source:
REZATOMIDINE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
REZATOMIDINE
×
Maximum Phase:
2
First Approval:
None
UNII:
W5LMZ0RC8I
Molecule Type:
Small molecule
Molecular Formula:
C13H16N2S
Molecular Weight:
232.35
AlogP:
3.84
PSA:
31.58
HBD:
2.0
HBA:
#RotB:
2.0
Source:
GISADENAFIL
(2)
Small molecule
Phosphodiesterase 5A inhibitor
Unknown
Investigational
Unknown
GISADENAFIL
×
Maximum Phase:
2
First Approval:
None
UNII:
S6G4R7DI1C
Molecule Type:
Small molecule
Molecular Formula:
C23H33N7O5S
Molecular Weight:
519.63
AlogP:
1.12
PSA:
135.54
HBD:
1.0
HBA:
#RotB:
10.0
Source:
AV-101
(2)
Small molecule
Glutamate [NMDA] receptor antagonist
Unknown
Investigational
Unknown
AV-101
×
Maximum Phase:
2
First Approval:
None
UNII:
77XLH9L40B
Molecule Type:
Small molecule
Molecular Formula:
C10H11ClN2O3
Molecular Weight:
242.66
AlogP:
0.91
PSA:
106.41
HBD:
3.0
HBA:
#RotB:
4.0
Source:
FISPEMIFENE
(2)
Small molecule
Estrogen receptor modulator
Unknown
Investigational
Unknown
FISPEMIFENE
×
Maximum Phase:
2
First Approval:
None
UNII:
3VZ2833V08
Molecule Type:
Small molecule
Molecular Formula:
C26H27ClO3
Molecular Weight:
422.95
AlogP:
5.66
PSA:
38.69
HBD:
1.0
HBA:
#RotB:
11.0
Source:
ORP-101
(2)
Small molecule
Kappa opioid receptor antagonist
Unknown
Investigational
Unknown
ORP-101
×
Maximum Phase:
2
First Approval:
None
UNII:
SE6KE496VO
Molecule Type:
Small molecule
Molecular Formula:
C60H84N2O8
Molecular Weight:
961.34
AlogP:
9.19
PSA:
102.32
HBD:
2.0
HBA:
#RotB:
13.0
Source:
RONICICLIB
(2)
Small molecule
Cyclin-dependent kinase inhibitor
Unknown
Investigational
Unknown
RONICICLIB
×
Maximum Phase:
2
First Approval:
None
UNII:
0W9Q8U337A
Molecule Type:
Small molecule
Molecular Formula:
C18H21F3N4O3S
Molecular Weight:
430.45
AlogP:
3.96
PSA:
108.19
HBD:
3.0
HBA:
#RotB:
7.0
Source:
GSK-2245035
(2)
Small molecule
Toll-like receptor 7 agonist
Unknown
Investigational
Unknown
GSK-2245035
×
Maximum Phase:
2
First Approval:
None
UNII:
5L3SX16QBQ
Molecule Type:
Small molecule
Molecular Formula:
C20H34N6O2
Molecular Weight:
390.53
AlogP:
2.93
PSA:
102.06
HBD:
2.0
HBA:
#RotB:
10.0
Source:
XL-281
(2)
Small molecule
Serine/threonine-protein kinase B-raf inhibitor
Unknown
Investigational
Unknown
XL-281
×
Maximum Phase:
2
First Approval:
None
UNII:
DW2NWI3TFN
Molecule Type:
Small molecule
Molecular Formula:
C24H19ClN4O4
Molecular Weight:
462.89
AlogP:
4.56
PSA:
107.55
HBD:
3.0
HBA:
#RotB:
3.0
Source:
FARGLITAZAR
(2)
Small molecule
Peroxisome proliferator-activated receptor gamma agonist
Unknown
Investigational
Unknown
FARGLITAZAR
×
Maximum Phase:
2
First Approval:
None
UNII:
3433GY7132
Molecule Type:
Small molecule
Molecular Formula:
C34H30N2O5
Molecular Weight:
546.62
AlogP:
6.61
PSA:
101.66
HBD:
2.0
HBA:
#RotB:
12.0
Source:
TILPISERTIB
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
TILPISERTIB
×
Maximum Phase:
2
First Approval:
None
UNII:
A8Y5K4G762
Molecule Type:
Small molecule
Molecular Formula:
C33H33ClN8O
Molecular Weight:
593.13
AlogP:
6.37
PSA:
113.45
HBD:
2.0
HBA:
#RotB:
7.0
Source:
GALLIC ACID
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
GALLIC ACID
×
Maximum Phase:
2
First Approval:
None
UNII:
632XD903SP
Molecule Type:
Small molecule
Molecular Formula:
C7H6O5
Molecular Weight:
170.12
AlogP:
0.5
PSA:
97.99
HBD:
4.0
HBA:
#RotB:
1.0
Source:
[18F]FLUOROMISONIDAZOLE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
[18F]FLUOROMISONIDAZOLE
×
Maximum Phase:
2
First Approval:
None
UNII:
8MSY49469G
Molecule Type:
Small molecule
Molecular Formula:
C6H8FN3O3
Molecular Weight:
188.15
AlogP:
0.12
PSA:
81.19
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ODALASVIR
(2)
Small molecule
Nonstructural protein 5A inhibitor
Unknown
Investigational
Unknown
ODALASVIR
×
Maximum Phase:
2
First Approval:
None
UNII:
OVR52K7BDW
Molecule Type:
Small molecule
Molecular Formula:
C60H72N8O6
Molecular Weight:
1001.29
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
LB80380
(2)
Small molecule
DNA disrupting agent
Unknown
Investigational
Unknown
LB80380
×
Maximum Phase:
2
First Approval:
None
UNII:
S9I9P4J8IU
Molecule Type:
Small molecule
Molecular Formula:
C22H34N5O8P
Molecular Weight:
527.52
AlogP:
3.24
PSA:
166.98
HBD:
1.0
HBA:
#RotB:
11.0
Source:
SEPRANOLONE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
SEPRANOLONE
×
Maximum Phase:
2
First Approval:
None
UNII:
3P8Z6V53MU
Molecule Type:
Small molecule
Molecular Formula:
C21H34O2
Molecular Weight:
318.5
AlogP:
4.6
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
1.0
Source:
NEZULCITINIB
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
NEZULCITINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
CXA4I8AH6A
Molecule Type:
Small molecule
Molecular Formula:
C30H37N7O2
Molecular Weight:
527.67
AlogP:
3.8
PSA:
104.38
HBD:
3.0
HBA:
#RotB:
6.0
Source:
GLYCERYL TRIOLEATE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
GLYCERYL TRIOLEATE
×
Maximum Phase:
2
First Approval:
None
UNII:
O05EC62663
Molecule Type:
Small molecule
Molecular Formula:
C57H104O6
Molecular Weight:
885.45
AlogP:
18.1
PSA:
78.9
HBD:
0.0
HBA:
#RotB:
50.0
Source:
VIPOGLANSTAT
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
VIPOGLANSTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EPETIRIMOD
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
EPETIRIMOD
×
Maximum Phase:
2
First Approval:
None
UNII:
9P5MH9F521
Molecule Type:
Small molecule
Molecular Formula:
C13H15N5
Molecular Weight:
241.3
AlogP:
2.22
PSA:
69.62
HBD:
1.0
HBA:
#RotB:
2.0
Source:
INDANTADOL
(2)
Small molecule
Glutamate [NMDA] receptor antagonist
Unknown
Investigational
Unknown
INDANTADOL
×
Maximum Phase:
2
First Approval:
None
UNII:
Z3867B9SQP
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
143
144
145
146
147
148
149
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA